Literature DB >> 337162

alpha-Glucosidase inhibitors. New complex oligosaccharides of microbial origin.

D D Schmidt, W Frommer, B Junge, L Müller, W Wingender, E Truscheit, D Schäfer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 337162     DOI： 10.1007/bf00483561

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN： 0028-1042


× No keyword cloud information.
  4 in total

1.  Glucosidase inhibition. A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia.

Authors:  W Puls; U Keup; H P Krause; G Thomas; F Hoffmeister
Journal:  Naturwissenschaften       Date:  1977-10

2.  Assay of intestinal disaccharidases.

Authors:  A Dahlqvist
Journal:  Enzymol Biol Clin (Basel)       Date:  1970

3.  Synthesis and chemistry of 4-amino-4,6-dideoxy sugars. II. Glucose.

Authors:  C L Stevens; P Blumbergs; F A Daniher; D H Otterbach; K G Taylor
Journal:  J Org Chem       Date:  1966-09       Impact factor: 4.354

4.  Studies on validamycins, new antibiotics. VI. Validamine, hydroxyvalidamine and validatol, new cyclitols.

Authors:  S Horii; T Iwasa; E Mizuta; Y Kameda
Journal:  J Antibiot (Tokyo)       Date:  1971-01       Impact factor: 2.649
  4 in total
  49 in total

1.  Crystal structures of human pancreatic alpha-amylase in complex with carbohydrate and proteinaceous inhibitors.

Authors:  V Nahoum; G Roux; V Anton; P Rougé; A Puigserver; H Bischoff; B Henrissat; F Payan
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Identification, cloning, expression, and characterization of the extracellular acarbose-modifying glycosyltransferase, AcbD, from Actinoplanes sp. strain SE50.

Authors:  M Hemker; A Stratmann; K Goeke; W Schröder; J Lenz; W Piepersberg; H Pape
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

Review 3.  Pharmacokinetic-pharmacodynamic relationships of Acarbose.

Authors:  T Salvatore; D Giugliano
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

4.  Genetic and Transcriptional Analyses of the Flagellar Gene Cluster in Actinoplanes missouriensis.

Authors:  Moon-Sun Jang; Yoshihiro Mouri; Kaoru Uchida; Shin-Ichi Aizawa; Masayuki Hayakawa; Nobuyuki Fujita; Takeaki Tezuka; Yasuo Ohnishi
Journal:  J Bacteriol       Date:  2016-07-28       Impact factor: 3.490

5.  Glucosidase inhibition. A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia.

Authors:  W Puls; U Keup; H P Krause; G Thomas; F Hoffmeister
Journal:  Naturwissenschaften       Date:  1977-10

Review 6.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

7.  Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics.

Authors:  J Gerard; P J Lefebvre; A S Luyckx
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients.

Authors:  C Schnack; G Röggla; A Luger; G Schernthaner
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  QSAR Studies on andrographolide derivatives as α-glucosidase inhibitors.

Authors:  Jun Xu; Sichao Huang; Haibin Luo; Guoji Li; Jiaolin Bao; Shaohui Cai; Yuqiang Wang
Journal:  Int J Mol Sci       Date:  2010-03-02       Impact factor: 5.923

10.  Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.

Authors:  Yoshiyuki Suzuki; Seiichiro Ogawa; Yasubumi Sakakibara
Journal:  Perspect Medicin Chem       Date:  2009-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.